White Paper · Mikaline Research 2026
Where will your pharmacy be in 2045?
The Italian pharmacy is at a historic crossroads. Between consolidation, the entry of capital and demographic decline, value is concentrating in the most organized structures. Pharmacy Outlook Italia 2026: the data, the scenarios and the 10 priorities to avoid falling behind.
INDEPENDENT RESEARCH · PDF · FREE · NO SPAM
The change underway
The market is growing. But the value is concentrating elsewhere.
Health demand will keep growing as the population ages. The problem is that economic value is shifting toward the larger, more organized pharmacies.
Capital enters
Dr. Max, Hippocrates, Farmagorà and the funds are acquiring the pharmacies with the best fundamentals.
Demographic decline
-4/5 million inhabitants by 2050 and up to 1,600 pharmacies at risk in inland areas.
Polarized market
33% of pharmacies generate 56% of turnover. The bottom third only 9%.
The value shifts
From revenue multiples to EBITDA: 7-10x in the cities, much less where demographics decline.
The research figures
The 2025 snapshot
€27.8 bn
Value of the pharmacy market 2025 (+4% on the previous year)
20 → 25%
Share of organized pharmacies: already in 2026
23%
Of the turnover generated by just ~2,000 pharmacies (top decile)
2-4%
Share to which small independents could shrink by 2045
Source: Pharmacy Outlook Italia 2026 — Mikaline Research, on IQVIA, ISTAT data and proprietary forecasting models.
The real news
It no longer matters whether you're independent or a chain. What matters is whether you can evolve.
The research is clear: there will be extremely innovative independent pharmacies and large organizations unable to make the most of their human capital. Success doesn't depend on ownership, but on the quality of management.
The challenge is no longer just to dispense medicines: it's to build an integrated pharmacy that combines clinical skills, managerial efficiency, technology and the relationship with the patient.
“Health demand will grow. But economic value will concentrate in the most organized structures.”
Inside the document
What's in the White Paper
A quantitative and managerial analysis of the future of the Italian pharmacy, from 2026 to 2045.
The 2025 market
Size, resilience, high-margin categories and the weight of e-commerce.
Why the chains perform
Average receipt, inventory turnover, non-pharma: the indicators compared.
The impact of demographics
Aging, depopulation of inland areas and pharmacies at risk.
The 2030-2045 scenarios
Three Mikaline projections on the competitive evolution of the sector.
The new economic value
From turnover to EBITDA: how the pharmacy's valuation will change.
Customer Experience
The patient journey and CX as a true competitive advantage.
The compass
The 10 strategic priorities
Mikaline Research's final recommendations for the pharmacy that wants to stay competitive.
An independent study by Mikaline Research (Milan), edited by the Mikaline Research study center. Compiled on public data, specialized databases and proprietary forecasting models. Servizi Farmacia Italia, in the person of Dr. Giuseppe Tura, contributed professional insight to the drafting of the document.
The questions we get asked
Legitimate doubts, clear answers
Is it useful even if I have a small pharmacy?
Above all. The research shows that size matters less than the ability to evolve: the document gives you the data and priorities to compete even as an independent, avoiding ending up in the bottom third of the market.
Is it a sales document?
No. It's an independent study by Mikaline Research based on IQVIA, ISTAT data and forecasting models. It sells nothing: it offers an objective picture for making better decisions.
How long is it?
It's a complete White Paper with executive summary, market analysis, 2030-2045 scenarios, the new economic valuation model, Customer Experience and 10 operational recommendations.
Why does Servizi Farmacia Italia share it?
Because SFI contributed to the research and believes in spreading a managerial culture of the pharmacy. We train owners to read these scenarios and act accordingly.
Is the data up to date?
Yes: they capture the 2025 market (€27.8 billion) and project the evolution through to 2045, with the consolidation and demographic dynamics already underway.
Download now, free
The future of the pharmacy doesn't wait. Get ready with the data.
Download Pharmacy Outlook Italia 2026 and discover where the market is heading, how your pharmacy's value will change and what to do today to stay competitive tomorrow.
Download the White Paper →